PCI The Journeys Within
CPHI 2026 – 23/07/2026

Current Edition

ramusmedical
Asia Pacific

Takeda’s Alunbrig improves PFS in phase 3 lung cancer trial

Takeda’s lung cancer drug Alunbrig (brigatinib) has significantly improved progression-free survival (PFS) in phase 3 ALTA-1L (ALK in lung cancer trial of AP26113 in ...
Continue Reading →
Europe

Artificial intelligence can detect eye disease as accurately as expert doctors

An artificial intelligence (AI) system that can spot signs of eye disease as accurately as expert doctors has been developed to help make sure serious eye problems a...
Continue Reading →
Europe

Orchard Therapeutics Appoints Jon Ellis to Board of Directors

Boston, USA and London, UK / B3C newswire / -- Orchard Therapeutics, a leading commercial-stage biotech company dedicated to transforming the lives of patients with r...
Continue Reading →
Europe

Trailblazing VIARES changes the standards for entry-level CRAs

VIARES is the first independent organization to achieve IAOCR 5 star accreditation for their industry-newcomers training course Maidenhead, United Kingdom and Vienna...
Continue Reading →
Europe

CRF Health Launches Self-Service Model for TrialConsent® Platform

Self-service Version Enables Sponsors and CROs to Take Control of eConsent Technology Plymouth Meeting, PA – 20 August 2018: CRF Health, the leading global provider o...
Continue Reading →
Europe

Benzodiazepines are associated with increased risk of Alzheimer’s disease

The use of benzodiazepines and related drugs (Z drugs) is associated with a modestly increased risk of Alzheimer’s disease, according to a recent study from the Univ...
Continue Reading →
news

New technique treats prostate cancer in just five radiotherapy sessions

A new clinical trial shows the benefits of an innovative form of radiation therapy, which delivers the radiation in only five sessions instead of the usual 37. A n...
Continue Reading →
news

Endometriosis drug approved by the FDA to reduce pain

A new drug is shown to ease three different types of endometrios Endometriosis is a condition affecting around 1 in 10 women in the United States, and around 200 mill...
Continue Reading →
Europe

Europe’s first allogeneic stem cell therapy rejected by NICE

Cost regulators for the NHS in England and Wales have not approved funding for TiGenix and Takeda’s Alofisel - the first allogeneic stem cell therapy to be approved ...
Continue Reading →
news

FDA approves first-of-its kind targeted RNA-based therapy to treat a rare disease

The U.S. Food and Drug Administration approved Onpattro (patisiran) infusion for the treatment of peripheral nerve disease (polyneuropathy) caused by hereditary tran...
Continue Reading →
Quotient
CPHI 2026 – 20/07/2026